Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H34ClN3O4.C7H8O3S |
| Molecular Weight | 660.22 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)S(O)(=O)=O.CN(C)[C@H]2CC[C@@H](CC2)[C@@]3(C)OC4=C(Cl)C=C(C(=O)NCC5=C(C)C=C(C)NC5=O)C(C)=C4O3
InChI
InChIKey=JSBKGJUYSLVFPF-WJQUPPJOSA-N
InChI=1S/C26H34ClN3O4.C7H8O3S/c1-14-11-15(2)29-25(32)20(14)13-28-24(31)19-12-21(27)23-22(16(19)3)33-26(4,34-23)17-7-9-18(10-8-17)30(5)6;1-6-2-4-7(5-3-6)11(8,9)10/h11-12,17-18H,7-10,13H2,1-6H3,(H,28,31)(H,29,32);2-5H,1H3,(H,8,9,10)/t17-,18-,26-;/m1./s1
| Molecular Formula | C26H34ClN3O4 |
| Molecular Weight | 488.019 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C7H8O3S |
| Molecular Weight | 172.202 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1500 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/ |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
VALEMETOSTAT plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT |
|
2230 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36150143/ |
200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered: |
VALEMETOSTAT plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
10800 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/ |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
VALEMETOSTAT plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT |
|
18100 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36150143/ |
200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered: |
VALEMETOSTAT plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
20.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/ |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
VALEMETOSTAT plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT |
|
9.46 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36150143/ |
200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered: |
VALEMETOSTAT plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
10% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/ |
200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered: |
VALEMETOSTAT plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 19:51:11 GMT 2025
by
admin
on
Tue Apr 01 19:51:11 GMT 2025
|
| Record UNII |
6N79I7X5II
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
850021
Created by
admin on Tue Apr 01 19:51:11 GMT 2025 , Edited by admin on Tue Apr 01 19:51:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1809336-93-3
Created by
admin on Tue Apr 01 19:51:11 GMT 2025 , Edited by admin on Tue Apr 01 19:51:11 GMT 2025
|
PRIMARY | |||
|
6N79I7X5II
Created by
admin on Tue Apr 01 19:51:11 GMT 2025 , Edited by admin on Tue Apr 01 19:51:11 GMT 2025
|
PRIMARY | |||
|
300000029324
Created by
admin on Tue Apr 01 19:51:11 GMT 2025 , Edited by admin on Tue Apr 01 19:51:11 GMT 2025
|
PRIMARY | |||
|
C168589
Created by
admin on Tue Apr 01 19:51:11 GMT 2025 , Edited by admin on Tue Apr 01 19:51:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|